Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

Iryna Schlackow, Seamus Kent, William Herrington, Jonathan Emberson, Richard Haynes, Christina Reith, Rory Collins, Martin J. Landray, Alastair Gray, Colin Baigent, Borislava Mihaylova, R. Collins, C. Bray, Y. Chen, A. Baxter, A. Young, M. Hill, C. Knott, A. Cass, B. Feldt-RasmussenB. Fellström, D. E. Grobbee, C. Grönhagen-Riska, M. Haas, H. Holdaas, L. S. Hooi, L. Jiang, B. Kasiske, U. Krairittichai, A. Levin, Z. A. Massy, V. Tesar, R. Walker, C. Wanner, D. C. Wheeler, A. Wiecek, T. Dasgupta, W. Herrington, D. Lewis, M. Mafham, W. Majoni, C. Reith, S. Parish, D. Simpson, J. Strony, T. Musliner, L. Agodoa, J. Armitage, Z. Chen, J. Craig, D. de Zeeuw, J. M. Gaziano, R. Grimm, V. Krane, B. Neal, V. Ophascharoensuk, T. Pedersen, P. Sleight, J. Tobert, C. Tomson

Research output: Contribution to journalArticlepeer-review

28 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease'. Together they form a unique fingerprint.